<

 
Data updated 2026-04-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18759209.2 (espacenet)  (Federated)  (European Patent Register), 20180803
Patent/reg. no. and dateDK/EP 3661514, 20250917
Publication date20200610
Priority no. and dateUS 201762541591 P, 20170804, US 201762584537 P, 20171110, US 201862639922 P, 20180307, US 201862671585 P, 20180515
EP pub. no. and date EP 3661514 20200610
Effective date
Applicant/ownerMyoKardia, Inc., 1000 Sierra Point Parkway
Brisbane, CA 94005, US
Applicant ref. no.PV2107DKEP
InventorSEMIGRAN, Marc J., 1000 Sierra Point Parkway
Brisbane, CA 94005, US,
LEE, June H., 1000 Sierra Point Parkway
Brisbane, CA 94005, US,
LAMBING, Joseph, 1000 Sierra Point Parkway
Brisbane, CA 94005, US,
GREEN, Eric, 1000 Sierra Point Parkway
Brisbane, CA 94005, US,
EVANCHIK, Marc, 1000 Sierra Point Parkway
Brisbane, CA 94005, US,
CARLSON, Timothy, 2331 Coronet Boulevard
Belmont, CA 94002, US,
ZHANG, David, 140 Park Avenue
San Carlos, CA 94070, US
RepresentativePatrade A/S, Ceresbyen 75, 8000 Århus C, DK
Opponent
IPC ClassA61K 31/513 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) 
TitleMAVACAMTEN TIL BEHANDLING AF HYPERTROFISK KARDIOMYOPATI
Int. application no.US2018045180
Int. publication no.WO2019028360
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact